Etxeberria, Iñaki http://orcid.org/0000-0003-2713-0836
Olivera, Irene
Bolaños, Elixabet
Cirella, Asunta
Teijeira, Álvaro
Berraondo, Pedro
Melero, Ignacio
Funding for this research was provided by:
Ministerio de Economía y Competitividad (SAF 2017-83267-C2-1R)
Fundación Científica Asociación Española Contra el Cáncer
Article History
Received: 31 March 2020
Revised: 24 April 2020
Accepted: 27 April 2020
First Online: 20 May 2020
Competing interests
: I. Melero is a paid consultant for Bristol-Myers Squibb, Roche, AstraZeneca, Pharmamar, Alligator, Numab, F-star, Servier, and MSD and reports receiving commercial research grants from Alligator, Bristol-Myers Squibb, Roche, and Pharmamar. No potential conflict of interest were disclosed by the other authors.